The in vitro drug interaction potential of dietary supplements containing multiple herbal components

被引:32
作者
Foti, Robert S. [1 ]
Wahlstrom, Jan L. [1 ]
Wienkers, Larry C. [1 ]
机构
[1] Amgen Pharmacokinet & Drug Metab, Biochem Biophys Grp, Seattle, WA 98110 USA
关键词
D O I
10.1124/dmd.106.012724
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Herbal-based remedies are widely used as alternative treatments for a number of ailments. In addition, the use of products that contain both single and multiple herbal constituents is becoming increasingly common. The work described in this report examined the in vitro drug interaction potential for a commonly used herbal cold remedy reported to contain a mixture of eight herbal components. Experiments conducted in human liver microsomes exhibited significant inhibition (< 10% of control activity remaining) of multiple cytochrome P450 (P450) isoforms, including CYP2B6, CYP2C9, and CYP2D6, by the herbal mixture. In an attempt to explain the observed P450 inhibition by the herbal mixture, individual active components were obtained and tested for inhibitory potency. Inhibition of multiple P450 activities by a single constituent, luteolin, was observed. Conversely, inhibition of a single isoform by several herbal components was noted for CYP2B6. Based on the data presented, it is concluded that mixtures of herbal components may exhibit multiple modes of P450 inhibition, indicating the potential for complex herbal-drug interaction scenarios to occur.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 16 条
[1]
BACHMANN KA, 2003, DRUG METABOLIZING EN, P311
[2]
Delgoda Rupika, 2004, Toxicol Rev, V23, P239, DOI 10.2165/00139709-200423040-00004
[3]
ECHIZEN H, 1993, J PHARMACOL EXP THER, V264, P1425
[4]
Herb-drug interactions: Review and assessment of report reliability [J].
Fugh-Berman, A ;
Ernst, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (05) :587-595
[5]
GRECO WR, 1995, PHARMACOL REV, V47, P331
[7]
The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9 [J].
Kent, UM ;
Aviram, M ;
Rosenblat, M ;
Hollenberg, PF .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) :709-715
[8]
Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes [J].
Kim, HJ ;
Lee, SB ;
Park, SK ;
Kim, HM ;
Park, YI ;
Dong, MS .
ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (10) :1114-1121
[9]
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures [J].
Komoroski, BJ ;
Zhang, SM ;
Cai, HB ;
Hutzler, JM ;
Frye, R ;
Tracy, TS ;
Strom, SC ;
Lehmann, T ;
Ang, CYW ;
Cui, YY ;
Venkataramanan, R .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (05) :512-518
[10]
Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205